Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Alexandre

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Sante Publique (Vandoeuvre-Les-Nancy, France)|August 28, 2018
[Evaluation of a new pharmacovigilance tool: Simplified online reporting for general practitioners]Xavier Humbert, Basile Chrétien, Marion Sassier, et al.
Archives of Cardiovascular Diseases|March 31, 2023
Atrial fibrillation, cancer and anticancer drugsJonaz Font, Paul Milliez, Alexandre-Boudjema Ouazar, et al.
BMJ Open|December 3, 2024
Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signalsJean-Matthieu L'Orphelin, Angélique Da Silva, Jean Cabon, et al.
Psychiatry Research|July 3, 2024
Antidepressants and fetal death: A systematic review and disproportionality analysis in the WHO safety database (VigiBase<sup>Ⓡ</sup>)Pierre Desaunay, Maxime Eslier, Joachim Alexandre, et al.
JAMA Oncology|October 14, 2021
Occurrence of Pancytopenia Among Patients With Cancer Treated With Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitors: A Pharmacoepidemiologic StudyPierre-Marie Morice, Basile Chrétien, Angélique Da Silva, et al.
Drug Safety - Case Reports|October 18, 2016
High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?Joachim Alexandre, Xavier Humbert, Marion Sassier, et al.
Archives of Cardiovascular Diseases|February 13, 2025
Diagnosis of cancer therapy-related cardiovascular toxicities: A multimodality integrative approach and future developmentsSimon Travers, Joachim Alexandre, Lauren A Baldassarre, et al.
Pediatric Blood & Cancer|April 21, 2025
Identification of Anticancer Drugs Associated With Cancer Therapy-Related Cardiac Dysfunction in Pediatrics-Analysis of the WHO Pharmacovigilance DatabaseFabien Labombarda, Jérémie Rouger, Damien Legallois, et al.
Journal of the American College of Cardiology|September 22, 2018
Cocaine and/or Marijuana Use and Myocardial InfarctionBasile Chrétien, Reynald Le Boisselier, Charles Dolladille, et al.
European Journal of Clinical Pharmacology|May 22, 2020
Direct acting oral anticoagulants and alopecia: to go further with data mining in pharmacovigilance databasesBasile Chrétien, Marion Sassier, Joachim Alexandre, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Sante Publique (Vandoeuvre-Les-Nancy, France)|August 28, 2018
[Evaluation of a new pharmacovigilance tool: Simplified online reporting for general practitioners]Xavier Humbert, Basile Chrétien, Marion Sassier, et al.
Archives of Cardiovascular Diseases|March 31, 2023
Atrial fibrillation, cancer and anticancer drugsJonaz Font, Paul Milliez, Alexandre-Boudjema Ouazar, et al.
BMJ Open|December 3, 2024
Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signalsJean-Matthieu L'Orphelin, Angélique Da Silva, Jean Cabon, et al.
Psychiatry Research|July 3, 2024
Antidepressants and fetal death: A systematic review and disproportionality analysis in the WHO safety database (VigiBase<sup>Ⓡ</sup>)Pierre Desaunay, Maxime Eslier, Joachim Alexandre, et al.
JAMA Oncology|October 14, 2021
Occurrence of Pancytopenia Among Patients With Cancer Treated With Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitors: A Pharmacoepidemiologic StudyPierre-Marie Morice, Basile Chrétien, Angélique Da Silva, et al.
Drug Safety - Case Reports|October 18, 2016
High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?Joachim Alexandre, Xavier Humbert, Marion Sassier, et al.
Archives of Cardiovascular Diseases|February 13, 2025
Diagnosis of cancer therapy-related cardiovascular toxicities: A multimodality integrative approach and future developmentsSimon Travers, Joachim Alexandre, Lauren A Baldassarre, et al.
Pediatric Blood & Cancer|April 21, 2025
Identification of Anticancer Drugs Associated With Cancer Therapy-Related Cardiac Dysfunction in Pediatrics-Analysis of the WHO Pharmacovigilance DatabaseFabien Labombarda, Jérémie Rouger, Damien Legallois, et al.
Journal of the American College of Cardiology|September 22, 2018
Cocaine and/or Marijuana Use and Myocardial InfarctionBasile Chrétien, Reynald Le Boisselier, Charles Dolladille, et al.
European Journal of Clinical Pharmacology|May 22, 2020
Direct acting oral anticoagulants and alopecia: to go further with data mining in pharmacovigilance databasesBasile Chrétien, Marion Sassier, Joachim Alexandre, et al.
Pageof 15